Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

B cells can both help and hinder the body's defense against melanoma.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.